# RhyGaze

**Canonical:** https://apis.io/providers/rhygaze/  
**Website:** https://rhygaze.com  
**APIs profiled:** 0

RhyGaze is a clinical-stage biotechnology company developing gene therapy treatments to restore vision for people with retinal degenerative diseases. Its platform combines optogenetic proteins that engineer photosensitivity into mammalian cells with gene therapy delivery tools that install light-sensing machinery into human eye cells, technology originating at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) in Switzerland. The team includes executives who helped develop and commercialize Luxturna, the first FDA-approved gene therapy for a genetic disease. RhyGaze operates from Basel, Switzerland and Philadelphia, Pennsylvania, and is backed by GV. As a therapeutics company it publishes no public developer API surface.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Life Sciences, Biotechnology, Gene Therapy, Ophthalmology, Optogenetics, Vision Restoration

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/rhygaze/). Scores are computed from the provider's own public artifacts under a published rubric.